WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Stock Ownership - Who owns Janux Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Janux Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Avalon Ventures Xi LP10% Owner2023-11-13849,854$5.87
$4.99MBuy
Jay LichterDirector2023-11-13849,854$5.87
$4.99MBuy
Tighe ReardonActing Chief Financial Officer2023-11-13849,854$5.87
$4.99MBuy
Ra Capital Management LPDirector2023-07-19495,008$12.46
$6.17MBuy

1 of 1

JANX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JANX insiders and whales buy or sell their stock.

JANX Shareholders

What type of owners hold Janux Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Avalon Ventures Xi LP25.60%13,224,399$637.55MInsider
Ra Capital Management LP17.74%9,165,652$441.88MInstitution
Fmr LLC9.04%4,671,213$225.20MInstitution
Tighe Reardon9.01%4,652,427$224.29MInsider
Bvf Inc8.87%4,579,818$220.79MInstitution
Jay Lichter8.67%4,479,492$215.96MInsider
Bregua Corp7.26%3,749,250$180.75MInsider
Orbimed Advisors LLC6.42%3,317,927$159.96MInstitution
Citadel Advisors LLC6.04%3,120,205$150.43MInstitution
Janus Henderson Group PLC3.74%1,931,477$93.12MInstitution

1 of 3

JANX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JANX54.14%45.86%Net Buying
CGON0.00%16.44%Net BuyingNet Buying
SMMT4.61%92.95%Net BuyingNet Buying
APGE82.46%11.78%Net Buying
CORT30.65%69.35%Net BuyingNet Buying
View Top Biotech Stocks

Janux Therapeutics Stock Ownership FAQ

Who owns Janux Therapeutics?

Janux Therapeutics (NASDAQ: JANX) is owned by 64.85% institutional shareholders, 54.93% Janux Therapeutics insiders, and 0.00% retail investors. Avalon Ventures Xi LP is the largest individual Janux Therapeutics shareholder, owning 13.22M shares representing 25.60% of the company. Avalon Ventures Xi LP's Janux Therapeutics shares are currently valued at $622.87M.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.